Heatlhy Living: December 17, 2019

By  | 

BANGOR, Maine (WABI) - Topics:
1. Age-Related Neovascular Macular Degeneration
2. Gene Therapy
3. Cell Therapy

Health insurance prices are increasing between five and ten percent in West Virginia for almost all plans in 2020, according to Insurance Commission data.

1. Benner JD, Morse LS, Toth CA, Landers MB 3rd, Hjelmeland LM. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. Arch Ophthalmol. 1991;109(12):1731-1736. doi:10.1001/archopht.1991.01080120115039.
2. Martel JN, Mahmoud TH. Subretinal pneumatic displacement of subretinal hemorrhage. JAMA Ophthalmol. 2013;131(12):1632-1635. doi:10.1001/jamaophthalmol.2013.5464.
3. Khan MA, Shahlaee A, Bansal AS, Maguire JI. Fluorescein-assisted subretinal tissue plasminogen activator (tPA) delivery for submacular hemorrhage. Retina. 2017;37(6):1203-1206. doi:10.1097/IAE.0000000000001349.
4. Chang W, Garg SJ, Maturi R, et al. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol. 2014;157(6):1250-1257. doi:10.1016/j.ajo.2014.02.007